Table 2.
Results for confirmatory factor analysis of the FKSI-19 instrument. Item reliabilities ≥ 0.40 are given in bold
| Factor | Indicator | Standardized factor loadings | Standardized estimate | Item reliability (R2) | ||
|---|---|---|---|---|---|---|
| Estimate | 95% CI | P value | ||||
| DRS-P | GP1a | 1.026 | 0.978–1.073 | < 0.001 | 0.843 | 0.710 |
| GP4a | 0.498 | 0.455–0.541 | < 0.001 | 0.527 | 0.278 | |
| C2a | 0.316 | 0.278–0.354 | < 0.001 | 0.390 | 0.152 | |
| HI7a | 0.999 | 0.957–1.042 | < 0.001 | 0.883 | 0.780 | |
| B1a | 0.678 | 0.630–0.727 | < 0.001 | 0.614 | 0.377 | |
| BRM3a | 0.118 | 0.099–0.136 | < 0.001 | 0.306 | 0.093 | |
| BP1a | 0.425 | 0.382–0.467 | < 0.001 | 0.463 | 0.214 | |
| L2a | 0.319 | 0.274–0.364 | < 0.001 | 0.336 | 0.113 | |
| HI12a | 1.001 | 0.958–1.045 | < 0.001 | 0.875 | 0.766 | |
| RCC2a | 0.048 | 0.027–0.070 | < 0.001 | 0.110 | 0.012 | |
| C6 | 0.357 | 0.308–0.405 | < 0.001 | 0.350 | 0.123 | |
| GF5 | 0.378 | 0.324–0.433 | < 0.001 | 0.331 | 0.110 | |
| DRS-E | GE6a | 1.226 | 1.185–1.267 | < 0.001 | 1.000 | 1.000 |
| TSE | GP2a | 0.409 | 0.371–0.446 | < 0.001 | 0.592 | 0.351 |
| C5a | 0.365 | 0.321–0.409 | < 0.001 | 0.455 | 0.207 | |
| GP5a | 0.467 | 0.420–0.515 | < 0.001 | 0.524 | 0.275 | |
| FWB | GF1 | 0.747 | 0.699–0.795 | < 0.001 | 0.673 | 0.453 |
| GF3 | 0.958 | 0.917–0.998 | < 0.001 | 0.909 | 0.827 | |
| GF7 | 1.023 | 0.978–1.067 | < 0.001 | 0.888 | 0.789 | |
CI confidence interval, DRS-E disease-related symptoms-emotional, DRS-P disease-related symptoms-physical, FWB function/well-being, TSE treatment side effects
aReverse-scored